Consolidated Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Nov. 03, 2013		Oct. 28, 2012		Oct. 30, 2011
Cash flows from operating activities:
Net income	$ 19,576	[1]	$ 29,855	[2],[3],[4],[5]	$ 20,208
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization of property, plant and equipment	65,994		78,623		86,661
Amortization of deferred financing costs and intangible assets	6,948		6,586		6,799
Debt extinguishment loss	0		0		27,399
Consolidation, restructuring and related charges	0		262		0
Share-based compensation	3,975		3,160		2,458
Deferred income taxes	(266)		(615)		(224)
Changes in assets and liabilities:
Accounts receivable	2,400		11,190		(1,806)
Inventories	(891)		4,683		(6,544)
Other current assets	(2,744)		(79)		223
Accounts payable, accrued liabilities and other	4,409		(1,116)		1,379
Net cash provided by operating activities	99,401		132,549		136,553
Cash flows from investing activities:
Purchases of property, plant and equipment	(63,792)		(96,978)		(82,121)
Investment in joint venture	0		(13,397)		(18,271)
Payments for intangible assets	(2,173)		(27)		(95)
Other	(272)		(1,541)		(250)
Net cash used in investing activities	(66,237)		(111,943)		(100,737)
Cash flows from financing activities:
Proceeds from long-term borrowings	0		25,000		17,000
Proceeds from convertible debt offering	0		0		115,000
Purchase of common stock of subsidiary	(32,374)		(15,598)		(9,878)
Repayments of long-term borrowings	(8,314)		(5,293)		(64,107)
Proceeds from share-based arrangements	884		653		828
Payments of deferred financing fees	(40)		(198)		(117)
Payments of expenses related to debt offering	0		0		(4,201)
Net cash provided by (used in) financing activities	(39,844)		4,564		54,525
Effects of exchange rate changes on cash and cash equivalents	4,252		2,945		642
Net increase (decrease) in cash and cash equivalents	(2,428)		28,115		90,983
Cash and cash equivalents at beginning of year	218,043		189,928		98,945
Cash and cash equivalents at end of year	215,615		218,043		189,928
Supplemental disclosure of non-cash information:
Capital lease obligation for purchases of property, plant and equipment	26,356		0		21,248
Accrual for property, plant and equipment purchased during year	17,502		5,052		6,869
Deposit related to facility purchase	0		2,000		0
Common stock issued to extinguish debt	$ 0		$ 0		$ 20,234

[1] Includes transaction expenses of $0.8 million, net of tax, in connection with the pending joint venture with DNP Photomask Technology Co., Ltd.

[2] Includes consolidation and restructuring charges of $1.1 million, net of tax, in connection with the discontinuance of manufacturing operations at the Company’s Singapore facility.

[3] Includes non-cash gain of $0.1 million, net of tax, in connection with subsequent measurement at fair value of warrants issued to purchase the Company’s stock.

[4] Includes consolidation and restructuring charges of $0.1 million, net of tax, in connection with the discontinuance of manufacturing operations at the Company’s Singapore facility.

[5] Includes consolidation and restructuring charges of $0.2 million, net of tax, in connection with the discontinuance of manufacturing operations at the Company’s Singapore facility.